Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Stem Cell, Inc.

http://us-stemcell.com/

Latest From U.S. Stem Cell, Inc.

Teleflex Subsidiary Faces Federal False Claims Investigation

Urology device developer NeoTract, which Teleflex purchased in 2017, is now under scrutiny for potential FCA violations. 

Commercial Enforcement

Teleflex Bets Percutaneous Laparoscopy Will Be MIS Game Changer

Story and Podcast: Teleflex Medical launched in March a novel portfolio of miniaturized percutaneous surgical instruments that have the same functionality as full-sized laparoscopic instruments, but allow surgeons to access the abdominal cavity using trocar-less entry and much smaller incisions than those required in traditional laparoscopy. Teleflex execs say the technology is a game changer, and the company hopes percutaneous laparoscopy will become the standard of care for the 4 million laparoscopic procedures performed annually in the US.

Medical Device Innovation

Warning Letter Close-Outs – September 2015

Twelve FDA close-out letters were released in September.

Medical Device Regulation

Teleflex Resuscitation System Recall Dubbed Class I

The company recalled its Hudson RCI Lifesaver resuscitation devices after it was found they were defective and could lead to injury or death if their oxygen intake ports get blocked.

Medical Device Regulation
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Other Names / Subsidiaries
    • Bioheart Inc.
UsernamePublicRestriction

Register